Loading clinical trials...
Loading clinical trials...
This study seeks to evaluate the long-term safety and effectiveness of nelotanserin for the treatment of visual hallucinations (VHs) and Rapid Eye Movement (REM) Sleep Behavior Disorder (RBD) in subje...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Axovant Sciences Ltd.
NCT04246437 · Autonomic Failure, Pure Autonomic Failure, and more
NCT07284290 · Dementia With Lewy Bodies, Parkinson Disease Dementia, and more
NCT03233646 · Alzheimer's Disease, Mild Cognitive Impairment, and more
NCT06098612 · Parkinson's Disease, Multiple System Atrophy, and more
NCT03672266 · Autistic Disorders Spectrum, Adhd, and more
US120
Birmingham, Alabama
US143
Little Rock, Arkansas
US114
Boca Raton, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions